Spruce Biosciences (SPRB)

• Market cap: $120M
• 1 day: 10.15%
• 5 days: -5.4%
• 1 month: -29.21%
• 3 months: 1,048.67%
• 6 months: 1,048.67%
• Year to date: 257.82%
• 1 year: 193.61%
• 5 years: -93.45%
• 10 years: -91.17%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20